YOU SEARCHED BY...
SEARCH BY...
Country
- Canada(4)
- Finland(1)
- Germany(6)
- India(5)
- Italia (1)
- Portugal(1)
- South Korea(1)
- Spain(3)
- Sweden(1)
- Switzerland(2)
- Turkey(1)
- United Kingdom(2)
- United States(52)
Contract Service Directory
Grifols International
Company Headquarters
152 Avinguda de la Generalitat
Sant Cugat del Vallès, CT 08174
Spain
Company Description
Grifols Partnership is a CDMO focused on added value injectable products, with a large international experience in the development and manufacturing of sterile drug products (small molecules) in glass vials and PP bags. Strict compliance with global manufacturing standards has earned us the highest accreditations, including authorizations by the US FDA, EU and US GMP and authorization for parametric release sterility.
Contract Service Directory
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Custom Manufacturing
- Filling, Vial
- Formulation Development
- Manufacturing, Dose Form, Sterile
- Manufacturing, Generics
- Manufacturing, Injectables
- Manufacturing, Parenterals, Large Volume
- Manufacturing, Parenterals, Small Volume
- Manufacturing, Veterinary
- Parenterals Development
- Parenterals, Vial Filling
- Preformulation
- Process Development/Scale-Up Services
- Process R&D
- Process Validation Studies
- Project Management
- QA/QC
- R&D Services
- Scale-Up
- Serialization
- Stability Studies
- Stability, ICH
- Sterile Filling
- Sterility Testing
- Technology Transfer
Related Content
-
-
Breaking News | CRO News | Promotions & Moves
Parexel Adds Experts to Regulatory Consulting Group
Four new hires from U.S. FDA and MHRA will serve as technical vice presidents12.10.19
-
Breaking News | Drug Development | Trials & Filings
SK Bio Gains FDA Approval for XCOPRI
Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval11.25.19
-
Breaking News | Collaborations & Alliances | Drug Development | Trials & Filings
Roche’s Risdiplam for SMA Granted Priority Review
FDA filing triggers $15M milestone to development partner PTC Therapeutics11.25.19
-
Biologics, Proteins, Vaccines | Biosimilars
Biopharma Over 20 Years
A look at the key trends that have impacted the biopharma industry over the years.K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19
-
cGMP Manufacture | Drug Development
Contract Pharma’s 20th Anniversary Series: Catalent
Elliott Berger of Catalent shares his insights on the past 20 years and what we can anticipate for the future of the industry and outsourcingKristin Brooks, Contract Pharma 11.08.19
-
-
Clinical Trial Materials
Overcoming the Small Molecule Bioavailability Challenge
Approximately 90% of preclinical compounds are estimated to face bioavailability challenges.David Lyon, Sr. Research Fellow, Lonza Pharma & Biotech 10.15.19
-
APIs | Cytotoxics and High Potency Manufacturing | Facilities
Flamma Arrives in the U.S.
Italian CDMO sets down roots in the U.S. market with purchase of Teva facility.Tim Wright, Editor, Contract Pharma 10.15.19
-
Bio News | Breaking News | Industry News | Promotions & Moves
AGC Biologics Bolsters Denmark Operations
Jeffrey D. Mowery named site head/general manager of Copenhagen facility10.04.19
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Industry News | Laboratory Testing
Frontage Expands Bioanalytical Capacity and Capabilities
To add 10,000 square feet of lab space to support biologic drug development, biomarkers and cell and gene therapy10.03.19
-
Bioanalytical Services | CRO News | Laboratory Testing
PPD Expands Bioanalytical Lab in Richmond, VA
The expansion includes growing the lab’s immunochemistry and biomarker space by 8,000 square feet09.19.19
-
PPD Expands Bioanalytical Lab Capabilities
Expansion includes growing the lab’s immunochemistry and biomarker space by 8,000 square feet09.19.19
-
Regulatory Affairs
Quality Metrics Feedback
A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholdersGil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19
-
Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
FDA Extends CRADA with CluePoints
Aims to further explore a data-driven approach to quality oversight in clinical trials09.11.19
-
cGMP Manufacture | Collaborations & Alliances
NIIMBL, FDA to Advance Innovation in Bio Manufacturing
CRADA enables FDA and NIIMBL to support investments in regulatory science research, and training needed to foster advanced manufacturing innovations08.01.19
-
Trials & Filings
FDA Accepts RedHill Biopharma’s NDA for Talicia
Commercial launch of H. pylori treatment is planned shortly following potential FDA approval07.16.19
-
Extractables and Leachables | Laboratory Testing
The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?
Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standardsKristin Brooks, Contract Pharma 07.11.19
-
APIs | Breaking News | Industry News
-
APIs | Breaking News | Facilities | Industry News
FLAMMA Acquires Teva’s Philadelphia cGMP Facility
Marks entry into the U.S. marketplace with labs & pilot plant07.01.19
-
Trials & Filings
Sierra’s Momelotinib Granted FDA Fast Track Designation
Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor06.19.19
-
APIs | Biosimilars | Drug Delivery | Drug Development | Fill/Finish | Formulation Development | Lyophilization | Parenterals | Supply Chain
Parenteral Outsourcing Trends
Contract Pharma asked a roundtable of business leaders from Symbiosis, Grifols, Althea, LSNE and Baxter to discuss key trends in the parenteral dosage development and manufacturing marketTim Wright, Editor 03.09.16
